Valar Labs is a company that develops artificial intelligence diagnostics for cancer treatment. It provides tests that analyze solid tumor pathology slides to report on tumor characteristics and therapy response indicators. Its products include Vesta, a test for bladder and prostate cancers, and biomarkers used in chemotherapy selection for pancreatic and metastatic hormone-sensitive prostate cancer. The company serves professionals and organizations in oncology research and clinical care.